Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

AQCA Study: Pre-PCI Virtual QFR for Planning PCI vs. Conventional Angiography

Several studies have used physiological assessment after a percutaneous coronary intervention (PCI) to improve clinical outcomes. However, results are not entirely conclusive. The limitations of using these physiological assessment methods are the need for extra measurements with increased procedure time, more radiation, and more contrast, which in turn leads to higher costs. 

Estudio AQVA: QFR virtual previo a la ATC para planificar angioplastia coronaria vs angiografía convencional

To counteract these limitations, several authors have proposed the use of virtual quantitative flow reserve (QFR) prior to PCI to plan the best strategy, allowing for the simulation of different therapeutic strategies and their corresponding results.

The aim of this multicenter, randomized study was to evaluate whether QFR-guided PCI is superior to angiography-guided PCI for optimal post-PCI QFR outcomes.

The primary endpoint (PEP) was the proportion of vessels with a final post-CTA QFR <0.90. The secondary endpoint (SEP) was the post-PCO QFR value, procedure duration, use of a contrast agent, number of stents, and stent length. Another secondary endpoint was cardiovascular death, incidence of acute myocardial infarction, and ischemia-guided revascularization of the treated vessel.

The study enrolled 300 patients, of whom 151 were randomized to QFR-guided PCI and 148 to angiography-guided PCI. Mean patient age was 70 years, and most subjects were men. The most frequent clinical presentation was chronic stable angina, followed by non-ST-segment elevation myocardial infarction (NSTEMI). The most treated artery was the anterior descending artery.

Read also: Deep Vein Arterialization: Have We Conquered “Non-Revascularizable” Critical Limb Ischemia?

The PEP was significantly more frequent in the angiography-guided PCI group, compared with the QFR-guided PCI group (p = 0.009). The main cause of suboptimal outcome in the angiography-guided group was underestimation of diseased segments outside the stents. There were no differences in the SEP in terms of procedure length, amount of contrast agent used, and radiation dose. However, the stent length and the number of stents were lower in the QFR-guided PCI group (p = 0.06; p = 0.08, respectively).

Conclusion

This study showed that QFR-guided PCI was superior to angiography-guided PCI to achieve an optimal physiological result after PCI, defined as post-PCI QFR ≥0.90. The QRF-based strategy changed operator planning in 25% of cases and was not linked to longer procedure times nor larger doses of contrast agent or radiation.

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: QFR-Based Virtual PCI or Conventional Angiography to Guide PCI The AQVA Trial.

Reference: Simone Biscaglia, MD et al J Am Coll Cardiol Intv 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...